Increasing awareness and knowledge of Alpha-gal Syndrome in the United States
Grant Opportunity Analysis
The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement grant titled "Increasing awareness and knowledge of Alpha-gal Syndrome in the United States." The primary objective of this funding opportunity is to enhance awareness, surveillance, and patient care related to Alpha-gal Syndrome (AGS), an emerging health condition that is not nationally notifiable. The grant seeks to support the formation of a professional association to disseminate knowledge about AGS, create educational resources for both the public and healthcare providers, and conduct enhanced public health surveillance, with a total estimated program funding of $10 million and awards ranging from $25,000 to $1 million. Interested applicants, including bona fide agents, must submit their applications electronically by May 1, 2026, with an anticipated award date of July 1, 2026. For further inquiries, applicants can contact Jeff Borchert at gqx1@cdc.gov or by phone at (970) 221-6494.
Eligible Applicants
Bona fide agents are eligible to apply. For more information about bona fide agents, please see the CDC webpage on Expediting the Federal Grant Process with an Administrative Partner located at https://www.cdc.gov/publichealthgateway/grantsfunding/expediting.html#Q2